Media coverage
12
Media coverage
Title Castle Biosciences Presents New Data Demonstrating the Impact of DecisionDx®-SCC Test Results on the Management of Medicare-Eligible Patients with Cutaneous Squamous Cell Carcinoma and One or More Risk Factors; Multiple poster presentations at the 2022 Fa Media name/outlet Business Wire Country/Territory United States Date 24/10/22 URL metabase.moreover.com/noarticleurl?type=psh&lni=66P8-XT01-JBG1-80NG-00000-00 Persons Matthew Goldberg Title Castle Biosciences Presents New Data Demonstrating the Impact of DecisionDx®-SCC Test Results on the Management of Medicare-Eligible Patients with Cutaneous Squamous Cell Carcinoma and One or More Risk Factors Media name/outlet Business Wire Country/Territory United States Date 24/10/22 URL www.businesswire.com/news/home/20221024005124/en/Castle-Biosciences-Presents-New-Data-Demonstrating-the-Impact-of-DecisionDx%C2%AE-SCC-Test-Results-on-the-Management-of-Medicare-Eligible-Patients-with-Cutaneous-Squamous-Cell-Carcinoma-and-One-or-More-Risk-Factors/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT Persons Matthew Goldberg Title Castle Biosciences Inc. (CSTL) Presents New Data Demonstrating Impact of DecisionDx-SCC Test Results on Management of Medicare-Eligible Patients with cSCC and One or More Risk Factors Media name/outlet Street Insider Country/Territory United States Date 24/10/22 URL https://www.streetinsider.com/Corporate+News/Castle+Biosciences+Inc.+%28CSTL%29+Presents+New+Data+Demonstrating+Impact+of+DecisionDx-SCC+Test+Results+on+Management+of+Medicare-Eligible+Patients+with+cSCC+and+One+or+More+Risk+Factors/20734503.html Persons Matthew Goldberg Title Castle Biosciences Presents New Data Demonstrating the Impact of DecisionDx®-SCC Test Results on the Management of Medicare-Eligible Patients with Cutaneous Squamous Cell Carcinoma and One or More Risk Factors Media name/outlet BioSpace Country/Territory United States Date 24/10/22 URL https://www.biospace.com/article/releases/castle-biosciences-presents-new-data-demonstrating-the-impact-of-decisiondx-scc-test-results-on-the-management-of-medicare-eligible-patients-with-cutaneous-squamous-cell-carcinoma-and-one-or-more-risk-factors/ Persons Matthew Goldberg Title Castle Biosciences Presents New Data Demonstrating the Impact of DecisionDx®-SCC Test Results on the Management of Medicare-Eligible Patients with Cutaneous Squamous Cell Carcinoma and One or More Risk Factors Media name/outlet Yahoo! News Country/Territory United States Date 24/10/22 URL https://www.yahoo.com/now/castle-biosciences-presents-data-demonstrating-110000632.html Persons Matthew Goldberg Title Castle Biosciences Presents New Data Demonstrating the Impact of DecisionDx®-SCC Test Results on the Management of Medicare-Eligible Patients with Cutaneous Squamous Cell Carcinoma and One or More Risk Factors Media name/outlet Yahoo! Finance Country/Territory United States Date 24/10/22 URL https://finance.yahoo.com/news/castle-biosciences-presents-data-demonstrating-110000632.html Persons Matthew Goldberg Title Castle Biosciences Presents New Data Demonstrating the Impact of DecisionDx®-SCC Test Results on the Management of Medicare-Eligible Patients with Cutaneous Squamous Cell Carcinoma and One or More Risk Factors Media name/outlet ADVFN UK Country/Territory United Kingdom Date 24/10/22 URL https://uk.advfn.com/stock-market/NASDAQ/CSTL/share-news/Castle-Biosciences-Presents-New-Data-Demonstrating/89362066 Persons Matthew Goldberg Title Castle Biosciences Presents New Data Demonstrating the Impact of DecisionDx®-SCC Test Results on the Management of Medicare-Eligible Patients with Cutaneous Squamous Cell Carcinoma and One or More Risk Factors Media name/outlet MarketScreener.com Country/Territory United States Date 24/10/22 URL https://www.marketscreener.com/quote/stock/CASTLE-BIOSCIENCES-INC-62745768/news/Castle-Biosciences-Presents-New-Data-Demonstrating-the-Impact-of-DecisionDx-SCC-Test-Results-on-the-42069357/ Persons Matthew Goldberg Title Castle Biosciences Presents New Data Demonstrating the Impact of DecisionDx®-SCC Test Results on the Management of Medicare-Eligible Patients with Cutaneous Squamous Cell Carcinoma and One or More Risk Factors Media name/outlet Ariva.de Country/Territory Germany Date 24/10/22 URL https://www.ariva.de/news/castle-biosciences-presents-new-data-demonstrating-the-10388293 Persons Matthew Goldberg Title $CSTL Castle Biosciences Presents New Data Demonstrating the Impact of DecisionDx®-SCC Test Results on the Management of Medicare-Eligible Patients with Cutaneous Squamous Cell Carcinoma and One or More Risk Factors Media name/outlet OTC Dynamics Country/Territory Canada Date 24/10/22 URL https://www.otcdynamics.com/cstl-castle-biosciences-presents-new-data-demonstrating-the-impact-of-decisiondx-scc-test-results-on-the-management-of-medicare-eligible-patients-with-cutaneous-squamous-cell-carcinoma-and-one/ Persons Matthew Goldberg Title Castle Biosciences Presents New Data Demonstrating the Impact of DecisionDx®-SCC Test Results on the Management of Medicare-Eligible Patients with Cutaneous Squamous Cell Carcinoma and One or More Risk Factors Media name/outlet Bakersfield.com Country/Territory United States Date 24/10/22 URL https://www.bakersfield.com/ap/news/castle-biosciences-presents-new-data-demonstrating-the-impact-of-decisiondx--scc-test-results-on/article_34935032-f7c1-59fb-b2ed-045ee4b1cac1.html Persons Matthew Goldberg Title Castle Biosciences Presents New Data Demonstrating the Impact of DecisionDx®-SCC Test Results on the Management of Medicare-Eligible Patients with Cut Media name/outlet Acrofan Date 23/10/22 URL https://us.acrofan.com/detail.php?number=742913 Persons Matthew Goldberg